FXR 10 Tablet contains Obeticholic acid 10mg, a potent farnesoid X receptor (FXR) agonist used primarily in the treatment of certain liver disorders. Obeticholic acid works by activating FXR, a nuclear receptor involved in regulating bile acid synthesis, lipid metabolism, and glucose homeostasis. This action helps reduce liver inflammation and fibrosis, making FXR 10 effective in managing conditions such as primary biliary cholangitis (PBC), especially in patients who have an inadequate response or intolerance to ursodeoxycholic acid. By modulating bile acid pathways, FXR 10 also aids in improving liver function tests and slowing disease progression. The tablet is typically administered orally once daily, with dosage adjustments based on clinical response and tolerability. Common side effects may include pruritus, fatigue, and abdominal discomfort, but these are generally manageable. FXR 10 should be used under medical supervision, particularly in patients with advanced liver disease or other comorbidities. It is important to follow prescribed dosing and consult healthcare providers for any adverse reactions or concerns. Overall, FXR 10 Tablet offers a targeted therapeutic option for improving liver health and managing chronic cholestatic liver diseases.